Cargando…

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer

MicroRNA (miRNA) is involved in the physiological and pathological processes of various malignancies. In this study, miRNA microarray analysis showed that miR-4634 levels in A549 cells increased significantly after everolimus (RAD001) treatment. Decreased expression of miR-4634 was also found in non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Sile, Zang, Hongjing, Zheng, Hongmei, Wang, Weiyuan, Wen, Qiuyuan, Zhan, Yuting, Yang, Yang, Ning, Yue, Wang, Haihua, Fan, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403585/ https://www.ncbi.nlm.nih.gov/pubmed/32753611 http://dx.doi.org/10.1038/s41598-020-70157-0

Ejemplares similares

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2022)

Overexpression of P4HA1 associates with poor prognosis and promotes cell proliferation and metastasis of lung adenocarcinoma
por: Ning, Yue, et al.
Publicado: (2021)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2020)

CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway
por: Wen, Qiuyuan, et al.
Publicado: (2016)

YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer
por: Ning, Yue, et al.
Publicado: (2023)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer
por: Ning, Yue, et al.
Publicado: (2020)

Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery
por: Zheng, Hongmei, et al.
Publicado: (2021)

Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection
por: Zheng, Hongmei, et al.
Publicado: (2019)

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration
por: Ning, Yue, et al.
Publicado: (2022)

YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma
por: Zhan, Yuting, et al.
Publicado: (2022)

Expression of cancer cell-intrinsic PD-1 associates with PD-L1 and p-S6 and predicts a good prognosis in nasopharyngeal carcinoma
por: Zhang, Yuting, et al.
Publicado: (2021)

New insights into the important roles of tumor cell-intrinsic PD-1
por: Zheng, Hongmei, et al.
Publicado: (2021)

Expression of DR5 and c-FLIP proteins as novel prognostic biomarkers for non-small cell lung cancer patients treated with surgical resection and chemotherapy
por: Zheng, Hongmei, et al.
Publicado: (2019)

Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma
por: Feng, Juan, et al.
Publicado: (2019)

Targeting ALDH1A1 to induce Necroptosis in Nasopharyngeal Carcinoma
por: Wang, Haihua, et al.
Publicado: (2022)

Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancer
por: Peng, Jinwu, et al.
Publicado: (2019)

Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
por: Zheng, Hongmei, et al.
Publicado: (2019)

High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patients
por: Zhou, Ying, et al.
Publicado: (2023)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017)

Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma
por: Wang, Haihua, et al.
Publicado: (2023)

AXL in cancer: a modulator of drug resistance and therapeutic target
por: Tang, Yaoxiang, et al.
Publicado: (2023)

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma
por: Wang, Weiyuan, et al.
Publicado: (2017)

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
por: Wang, Haihua, et al.
Publicado: (2022)

Long non-coding RNAs associated with non-small cell lung cancer
por: Zhan, Yuting, et al.
Publicado: (2017)

Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses
por: Zang, Hongjing, et al.
Publicado: (2020)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
por: Zheng, Hongmei, et al.
Publicado: (2018)

Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma
por: Wang, Weiyuan, et al.
Publicado: (2014)

Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells
por: Lin, Ji-Fan, et al.
Publicado: (2016)

Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
por: Agarwala, Sanjiv S., et al.
Publicado: (2010)

New insights into the important roles of phase seperation in the targeted therapy of lung cancer
por: Zou, Ying, et al.
Publicado: (2023)

RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth
por: Nyfeler, Beat, et al.
Publicado: (2012)

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2009)

The Altered Metabolic Molecular Signatures Contribute to the RAD001 Resistance in Gastric Neuroendocrine Tumor
por: Pan, Jie, et al.
Publicado: (2020)

RAD001 targeted HUVECs reverses 12‐lipoxygenase‐induced angiogenesis in oesophageal squamous cell carcinoma
por: Chen, Xue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jombh6iek34ea9n7jb7ve2ohqc